You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Attention Score in Context
| Title |
Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in vitro
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, November 2013
|
| DOI | 10.1186/2051-1426-1-s1-p263 |
| Authors |
Reiko Yamada, Kristopher Steward, Gataree Ngarmchamnanrith, Ryan Trinh, Sanjay Khare, Raj Sachdev, Iqbal Grewal, Sherie Morrison, John Timmerman |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2019.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,057
of 3,421 outputs
Outputs of similar age
#77,459
of 228,798 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#26
of 62 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,798 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.